Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artículo científico |
| Langue: | en |
| Publié: |
Universidad de Chile
2011
|
| Sujets: | |
| Accès en ligne: | https://www.redalyc.org/articulo.oa?id=55420909009 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1866558606859567104 |
|---|---|
| author | Carolina Martin |
| author_facet | Carolina Martin |
| contents | Ethical Health Technology Assessment in Latin America: Lessons from Canada and Argentina Carolina Martin Bryn Williams-Jones María Graciela de Ortúzar Filosofía policy Canada genetics bioethics Argentina A wide array of biomedical and genetic technologies is becoming available in both developed and developing nations. This situation is the cause of growing concern for health policy makers who must evaluate the utility of these technologies for their inclusion in public health insurance programs. Ideally, policy makers would have the information necessary to rationally allocate scarce resources, prioritise technologies, and ensure fair access to necessary health care services. The reality, however, is that policy makers often do not have such information. In this paper, we argue that the field of Health Technology Assessment (HTA), through the integration of ethical analyses (i.e., an "ethical HTA"), can enable Argentinean and other Latin American policy makers to better understand the soco-ethical concerns raised by new biotechnologies. 2011 artículo científico 0717-5906 https://www.redalyc.org/articulo.oa?id=55420909009 en http://www.redalyc.org/revista.oa?id=554 Acta Bioethica application/pdf Universidad de Chile Acta Bioethica (Chile) Num.2 Vol.17 |
| format | Artículo científico |
| id | redalyc_55420909009 |
| language | en |
| publishDate | 2011 |
| publisher | Universidad de Chile |
| spellingShingle | Ethical Health Technology Assessment in Latin America: Lessons from Canada and Argentina Carolina Martin Filosofía policy Canada genetics bioethics Argentina Ethical Health Technology Assessment in Latin America: Lessons from Canada and Argentina Carolina Martin Bryn Williams-Jones María Graciela de Ortúzar Filosofía policy Canada genetics bioethics Argentina A wide array of biomedical and genetic technologies is becoming available in both developed and developing nations. This situation is the cause of growing concern for health policy makers who must evaluate the utility of these technologies for their inclusion in public health insurance programs. Ideally, policy makers would have the information necessary to rationally allocate scarce resources, prioritise technologies, and ensure fair access to necessary health care services. The reality, however, is that policy makers often do not have such information. In this paper, we argue that the field of Health Technology Assessment (HTA), through the integration of ethical analyses (i.e., an "ethical HTA"), can enable Argentinean and other Latin American policy makers to better understand the soco-ethical concerns raised by new biotechnologies. 2011 artículo científico 0717-5906 https://www.redalyc.org/articulo.oa?id=55420909009 en http://www.redalyc.org/revista.oa?id=554 Acta Bioethica application/pdf Universidad de Chile Acta Bioethica (Chile) Num.2 Vol.17 |
| title | Ethical Health Technology Assessment in Latin America: Lessons from Canada and Argentina |
| topic | Filosofía policy Canada genetics bioethics Argentina |
| url | https://www.redalyc.org/articulo.oa?id=55420909009 |